Searched for
NEW INJECTABLE FACILITY
Punjab drug body finds critical lapses at Jackson Laboratories' manufacturing facility in AmritsarThe Punjab FDA has taken decisive action by revoking the manufacturing licence of Jackson Laboratories in Amritsar due to severe regulatory...- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- American scientists and ranchers are racing to stop a flesh-eating fly after 15 animal cases turned up in Texas and New Mexico, and the battle could take more than a yearFlesh-eating maggots, the New World screwworm, have reappeared in Texas and New Mexico, infecting livestock and at least one dog. Driven by...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Natural gas prices rebound as inventories tighten, LNG exports rise: Motilal OswalNatural gas prices are climbing back up. This recovery is driven by lower stored gas, increased power sector use, and more US liquefied nat...
- Explained: Why RBI’s FCNR(B) and ECB swap window could be a game changer for banksRBI’s FCNR(B) and ECB swap windows aim to boost liquidity, stabilise the rupee and ease funding costs for banks. Attractive returns for NRI...
- At Musk's Starbase, the rise of SpaceX brings fortunes and fracturesIn Texas, SpaceX's bustling Starbase is a double-edged sword, fueling economic growth while drawing thrill-seekers to the area. Unfortunate...
- At Elon Musk's Starbase, the rise of SpaceX brings fortunes and fracturesSpaceX's rapid expansion in South Texas, centred around its Starbase facility, is bringing economic benefits and global attention. However,...
- Bio Medica Laboratories shares to debut today. Here's what GMP suggests ahead of listingBio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading a...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsAs the stock market witnesses a recovery, what one should watch for is market breadth. Also, check which sectors are leading the rally. Why...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- ET Prime Special Series: Multibagger or IBC - Part 57: Forging firm that supplies Tata, M&M, JCB. Nobody talks about it enoughFor over four decades, one company has been making crankshafts quietly and precisely, supplying customers from Tata Motors to Liebherr to M...
- Zydus Biologics’ Ahmedabad injectable facility gets 7 observations in USFDA inspectionZydus Lifesciences has made headlines as its Zydus Biologics injectable plant in Ahmedabad underwent a USFDA inspection between April 27 an...
- Emcure eyes India growth, global deals amid strong demandEmcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in I...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThe spike in crude oil prices has again created trouble for the Nifty and Sensex, as it has done a number of times in the past two months. ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Lupin receives USFDA's establishment inspection report for its Nagpur facilityThe establishment inspection report (EIR) was issued after the last inspection of the facility conducted from October 17-29, 2022, the comp...
Load More
